| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 05/07/2008 | EP1918300A2 Peptide-based immunization therapy for treatment of atherosclerosis |
| 05/07/2008 | EP1608627B1 Bicyclic anilide spirohydantoin cgrp receptor antagonists |
| 05/07/2008 | EP1558597B1 Continuous process for the production of optically pure (s)-beta hydroxy-gamma-butyrolactone |
| 05/07/2008 | EP1347981B1 Condensed purine derivatives as a 1 adenosine receptor antagonists |
| 05/07/2008 | CN101172160A Interferon gamma conjugates |
| 05/06/2008 | US7368475 high and selective activity against Cytomegalovirus |
| 05/06/2008 | US7368473 Paclitaxel enhancer compounds |
| 05/06/2008 | US7368448 2-(arylalkoxy)-1-phenylethylamine derivatives as NK1 antagonist and serotonin reuptake inhibitors |
| 05/06/2008 | US7368428 Contacting tumor cells to glycoprtorein 88 (GP88) antagonists (e.g., anti-GP88 antibodies, anti-GP88 antisense nucleic acids, GP88 siRNA, and small molecules); antiestrogen and cytotoxic therapy |
| 05/02/2008 | WO2005013885A3 Pharmaceutical compositions and methods for accelerating wound healing |
| 05/01/2008 | US20080103292 Glycopeptide derivatives and pharmaceutical compositions containing the same |
| 05/01/2008 | US20080102136 Reactive nanoparticles as destructive adsorbents for biological and chemical contamination |
| 05/01/2008 | US20080102083 Compositions and Methods for the Preparation of Human Growth Hormone Glycosylation Mutants |
| 05/01/2008 | US20080102056 Marketing System for Improving Patient Compliance and Methods and Devices Relating to Same |
| 05/01/2008 | US20080102037 Stable pharmaceutical budesonide preparation for producing propellant-free aerosols |
| 04/30/2008 | CN100384824C Acetyl 2-hydroxy-1, 3-diaminoalkanes |
| 04/30/2008 | CN100384413C Combination of selected opioids with muscarine antagonists for treating urinary incontinence |
| 04/29/2008 | US7365224 In polymorphic Form A free of other polymorphic forms, used as an antiallergen to treat, e.g., bronchial asthma; high solubility and bioavailability |
| 04/29/2008 | US7365223 Method for selective targeting of apoptotic cells and small molecule ligands used thereof |
| 04/29/2008 | US7365205 Diamine derivatives |
| 04/29/2008 | US7364756 Anti-virus hydrophilic polymeric material |
| 04/29/2008 | US7364576 Method and assembly for treating pain of liquid nitrogen therapy |
| 04/29/2008 | CA2280133C Method for detecting abnormal epithelial cell shedding |
| 04/24/2008 | US20080097117 chemical intermediates for making antiinflammatory agents treating autoimmune disease; 1-[2-(Fluoren-3-yl)ethyl]-(4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine drug |
| 04/24/2008 | US20080096929 enzyme myeloperoxidase inhibitor; 5-Phenoxymethyl-4-(dihydrofuran-2-one-3-yl)-2,4-dihydro-[1,2,4]triazole-3-thione; treatment or prophylaxis of neuroinflammatory disorders including multiple sclerosis, Alzheimer's disease, Parkinson's disease and stroke, COPD, asthma, inflammatory bowel disease |
| 04/24/2008 | US20080096892 C-Kit Modulators And Methods Of Use |
| 04/24/2008 | US20080095855 Taste Masking Granules |
| 04/24/2008 | US20080095788 Vaccines |
| 04/23/2008 | EP1648527A4 Stabilization and ionic triggering of nitric oxide release |
| 04/23/2008 | EP1578431A4 Fat regulation |
| 04/23/2008 | EP1261316B1 Device for the delivery of oral drugs |
| 04/23/2008 | CN101164623A Compositions comprising viruses and methods for concentrating virus preparations |
| 04/23/2008 | CN101164559A Formulations useful in the treatment of male and female impotence |
| 04/23/2008 | CN101164548A Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist |
| 04/23/2008 | CN100383141C Pyrazolo [4,3-d] pyrimidine derivatives |
| 04/23/2008 | CN100383129C Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 04/22/2008 | US7361686 Compounds for the treatment of metabolic disorders |
| 04/22/2008 | US7361352 Influenza immunogen and vaccine |
| 04/22/2008 | US7361339 Methods for reducing morality associated with acute myocardial infarction |
| 04/22/2008 | CA2276661C Personal wash liquid composition comprising low viscosity oils pre-thickened by non-antifoaming hydrophobic polymers |
| 04/22/2008 | CA2150642C Tablet, capsule, or granule comprising desogestrel |
| 04/17/2008 | WO2005020903A3 Methods of improving the safety of zonisamide therapy |
| 04/17/2008 | US20080090996 Thrombopoietin mimetics |
| 04/17/2008 | US20080090787 Thrombopoietin mimetics |
| 04/17/2008 | US20080090783 LPA Receptor Agonists and Antagonists and Methods of Use |
| 04/17/2008 | US20080090752 Anti-tumor vasculature effects of human serum albumin derivatives |
| 04/17/2008 | US20080089934 Soft capsules, solid dosage forms; heating, hydrating, mixing, solubilizing a high solids, low moisture film-forming mixture to form a homogeneous molten composition, wherein said temperature is at or above the solubilizing temperature, feeding into pump, cooling; thermoreversible gel films |
| 04/17/2008 | US20080089931 EphA2, EphA4 and LMW-PTP and methods of treatment of hyperproliferative cell disorders |
| 04/16/2008 | EP1911763A2 Compositions for the treatment of gastrointestinal disorders |
| 04/16/2008 | EP1911445A2 Stable pharmaceutical formulation comprising an HMG-COA reductase inhibitor |
| 04/16/2008 | EP1646670A4 Self-crosslinkable poly(caprolactone fumarate) |
| 04/16/2008 | EP1572154A4 Medical devices employing novel polymers |
| 04/16/2008 | EP1165549B1 C7 carbamoyloxy substituted taxanes as antitumor agents |
| 04/16/2008 | CN100381173C Antitumor agents comprising a targeting portion and an immune response triggering portion |
| 04/15/2008 | US7358274 Methods for treating or preventing cancer using Benzopyranone Compounds |
| 04/15/2008 | US7358226 The localized, targeted delivery of a drug or contrast agent for imaging by administering and concentrating a carrier by exposing it to a radiation force generated by ultrasound waves at a frequency and pressure combination; rupturing;affecting tissue permeability or altering cell physiology |
| 04/15/2008 | CA2411468C Thrombopoietin mimetics |
| 04/15/2008 | CA2285340C Antiperspirant stick with improved characteristics |
| 04/10/2008 | WO2004100892A3 Novel fibroblast growth factors and methods of use thereof |
| 04/10/2008 | US20080085325 Dialysis Solution, Formulated And Stored In Two Parts, Comprising Phosphate |
| 04/09/2008 | EP1572133B1 Method for identifying modulators of human orexin-2 receptor |
| 04/09/2008 | CN101156861A Combretastatin a-4 phosphate prodrug salts with nitrogen-containing compounds |
| 04/09/2008 | CN100379743C New oxabispidine compound useful in treatment of cardiac arrhythmias |
| 04/09/2008 | CN100379739C Process for preparing azacycloalkanoylaminothiazoles |
| 04/09/2008 | CN100379433C Method of treating diabetes by using plant argyrolobium roseum extract |
| 04/09/2008 | CN100379418C The use of antimuscarinic drugs |
| 04/09/2008 | CN100379405C Method of preparing dry powder inhalation compositions |
| 04/08/2008 | US7355079 Thyronamine derivatives and analogs and methods of use thereof |
| 04/08/2008 | US7354907 immunomer comprising two or more oligonucleotide branches linked together; can cause immune stimulation across species lines; less expensive to make |
| 04/08/2008 | US7354905 Thrombosis therapy; anticoagulants |
| 04/08/2008 | CA2271126C Method of treating bronchitis with uridine triphosphates and related compounds |
| 04/03/2008 | WO2005004794A3 Method of treating neurodegenerative disease |
| 04/03/2008 | WO2004098511A3 Methods and devices for creating electrical block at specific targeted sites in cardia tissue |
| 04/03/2008 | US20080081050 Vaccine against streptococcus pneumoniae |
| 04/03/2008 | US20080078036 Dye composition for keratin fibers, with a cationic direct dye and a substantive polymer |
| 04/02/2008 | EP1905449A2 Vaccines |
| 04/02/2008 | EP1701733B1 Surface protection of exposed biological tissues |
| 04/02/2008 | EP1687447A4 Methods of identifying individuals at risk of perioperative bleeding, renal dysfunction or stroke |
| 04/02/2008 | CN101152574A Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome |
| 04/02/2008 | CN101152573A Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome |
| 04/02/2008 | CN101152160A Oral pharmaceutical formulation containing ibandronate |
| 04/02/2008 | CN100378118C Pharmaceutical compositions having appetite suppressant activity |
| 04/02/2008 | CN100378100C Pyrazolo(4,3-d)pyrimidine derivatives |
| 04/02/2008 | CN100378074C 2-,3-4- or 5-substituted-n1-(benzensulfonyl)indoles and their use in therapy |
| 04/02/2008 | CN100377714C Application of steroidal sapogenins and their derivatives in medicine preparation |
| 04/01/2008 | US7351858 Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance |
| 04/01/2008 | US7351830 Formed by selective phosphorylation of phenpanstatin with tetrabutylammonium dihydrogen phosphate and dicyclohexylcarbodiimide in pyridine followed by cation exchange; cancer cell inhibitors |
| 04/01/2008 | US7351821 Oxabispidine compounds useful in the treatment of cardiac arrhythmias |
| 04/01/2008 | US7351791 Intermediate for preparing glycopeptide derivatives |
| 04/01/2008 | US7351698 Androgen receptor modulators and methods of use thereof |
| 04/01/2008 | US7351690 Knockout identification of target-specific sites in peptides |
| 04/01/2008 | US7351686 Method for neuronal protection in amyotrophic lateral sclerosis by a vaccine comprising Copolymer-1 or Copolymer-1 related peptides |
| 04/01/2008 | US7351193 Treatment of age-related macular degeneration |
| 04/01/2008 | CA2432578C Quinazolone derivatives as alpha 1a/b adrenergic receptor antagonists |
| 04/01/2008 | CA2145661C Pyran-2-ones and 5,6-dihydropyran-2-ones useful for treating hiv and other retroviruses |
| 03/27/2008 | WO2004069200A3 Specific inhibitors of nfat activation by calcineurin and their use in treating immune-related diseases |
| 03/27/2008 | WO2004066943A3 Methods for diagnosis anf monitoring of neurological disease by detection of an encephalotoxin |
| 03/27/2008 | US20080076703 Compositions and methods for the enhanced uptake of therapeutic agents through the bladder epithelium |
| 03/27/2008 | US20080076177 Plasmid comprising nucleotide sequences coding vaccine specific to newcastle disease virus hemagglutinin-neuraminidase (HN) for use in prevention and treatment of viral diseases in plants |
| 03/27/2008 | US20080075773 Solid oral composition comprising 3-(5-methoxy-1H-indol-3-yl-methylene)-N-pentylcarbazimidamide or salt and disintegrant comprising crospovidone, sodium starch glycolate, carboxymethylcellulose sodium, sodium alginate; for administering active agents which are poorly soluble in water or acid sensitive |